The novel therapy of tirzepatide peptide represents a significant breakthrough in the handling of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide584941.bloginwi.com/75939331/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment